Nasdaq
$1.70▲ 1.65%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $141.2MShares out 83.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
27- 3d agoAfter-hours26.10.22 05:27DEF 14AOther#●●●#●●●
Pyxis Oncology, Inc.
Pyxis Oncology will hold a special meeting of stockholders on November 13, 2026, to vote on increasing the number of authorized shares of common stock from 190 million to 380 million. This proposal aims to expand the company's capacity to issue shares for future capital raising and general corporate purposes.…more
$1.70+1.65%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.9After-hours26.10.10 06:08PRE 14AOther
Pyxis Oncology, Inc.
Pyxis Oncology will hold a special meeting of stockholders on November 13, 2026, to vote on an amendment to increase the number of authorized shares of common stock from 190 million to 380 million. This proposal aims to provide the company with greater capital structure flexibility.…more
$1.70+1.65%vs prev closeView filingShare - 10.9Regular26.10.10 03:49SCHEDULE 13G/AOwnership
Pyxis Oncology, Inc.
GordonMD Global Investments LP and Craig D. Gordon have filed a Schedule 13G regarding their ownership of Pyxis Oncology, Inc. common stock. The filing is dated October 9, 2026, and confirms a joint filing agreement among the associated entities including GordonMD Global Investments GP LLC and GordonMD Long Biased GP LLC.…more
$1.70+1.65%vs prev closeView filingShare
26 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.2Pre-market26.10.02 20:00Bullish#●●●#●●●#●●●
Pyxis Oncology Closes Public Offering of Up to $282.6 Million
Pyxis Oncology has completed a public offering raising up to $282.6 million to fund the development of its clinical-stage cancer therapeutics. The offering involves the issuance of common stock and warrants, which may lead to potential shareholder dilution.…more
$1.70+1.65%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.30Overnight26.09.30 15:56
●●●●●●●● ●●●●● ●●●●●●
Pyxis Oncology has priced a $110 million offering of common shares and warrants. The issuance of new shares and warrants is expected to result in significant dilution for existing shareholders.…more
$1.70+1.65%vs prev closeShareBenzinga - 9.30Overnight26.09.30 14:11
●●●●●●●● ●●●●● ●●●●●●
Pyxis Oncology has announced a public offering of common stock and warrants to raise up to $282.6 million for clinical development. The issuance of new shares and warrants may lead to significant dilution for existing shareholders.…more
$1.70+1.65%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report